GCTK Stock Is Soaring Pre-Market Today — What Is Fueling The Surge?

Glucotrack Inc. (GCTK) shares soared nearly 15% in Friday’s pre-market trade after the company announced that it is in a position to file an Investigational Device Exemption (IDE) for its glucose monitoring technology in the second quarter (Q2) with the U.S. Food and Drug Administration.

Glucotrack cited critical operational milestones achieved by the company in developing its continuous blood glucose monitoring (CBGM) technology.

Retail sentiment on Stocktwits around Glucotrack trended in the ‘bullish’ territory at the time of writing.

Get updates to this story developing directly on Stocktwits.

Also See: Nvidia CEO Huang’s 200 Rubin Pods A Week Claim Sparks Debate – Here's Why Analysts Aren't Buying The Math

For updates and corrections, email newsroom[at]stocktwits[dot]com.